References
Leeming JP, Holland KT, Cuniffe WJ. The microbial colonization of inflamed acne vulgaris lesions. Br J Dermatol 1988; 118: 203–8
Eady EA, Cove JH, Holland KT, et al. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol 1989; 121: 51–7
Kawabata S, Ohguro K, Mukai F, et al. Bacteriological evaluation of OPC-7251, a new pyridone caboxylic acid antimicrobial agent. I. In vitro antibacterial activity. Jpn J Chemother 1989; 37: 1160–78
Kawabata S, Masada H, Wakebe H, et al. Bacteriological evaluation of OPC-7251, a new pyridone carboxylic acid antimicrobial agent. II. Therapeutic effect of OPC-7251 cream on experimental infection model in mice. Jpn J Chemother 1989; 37: 1179–83
Eady EA, Ross JI, Cove JH, et al. The effects of oral erythromycin therapy for acne on the development of resistance in cutaneous staphylococci and propionibacteria In: Marks R, Plewig G, editors. Acne and related disorders. London: Martin Dunitz, 1989: 265–70
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vogt, K., Hahn, H., Hermann, J. et al. Antimicrobial Evaluation of Nadifloxacin (OPC-7251), a New Topical Quinolone, in Acne Vulgaris. Drugs 49 (Suppl 2), 266–268 (1995). https://doi.org/10.2165/00003495-199500492-00065
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199500492-00065